Liofilizado: 2-8C
When used in the right formulation, it can be a gentle but effective option, especially for patients who need ongoing support rather than short-term suppression
doi: 10.3389/fnut.2024.1433390 Received 15 May 2024 Accepted 30 September 2024 Published 30 October 2024 Volume 11 - 2024 Edited by Anna Maria Aloisi, University of Siena, Italy Reviewed by Vahidreza Ostadmohammadi, Kashan University of Medical Sciences, Iran Anna Petroni, University of Siena, Italy Thomas Herdegen, University of Kiel, Germany Updates Copyright 2024 Hajhashemy, Golpour-Hamedani, Eshaghian, Sadeghi, Khorvash and Askari
5 Conclusions In these studies, within the limitations of small sample sizes, no clinically relevant differences were observed in cagrilintide pharmacokinetics in people with renal or hepatic impairment compared with those with normal function
Feb 24, 2026 You checked the vial